tiprankstipranks
Advertisement
Advertisement
Camp4 Therapeutics participates in a conf call hosted by Cantor Fitzgerald
PremiumThe FlyCamp4 Therapeutics participates in a conf call hosted by Cantor Fitzgerald
1M ago
CAMP4 Therapeutics updates corporate investor presentation materials
Premium
Company Announcements
CAMP4 Therapeutics updates corporate investor presentation materials
3M ago
CAMP4 Therapeutics Restructures Leases and Expands Facilities
Premium
Company Announcements
CAMP4 Therapeutics Restructures Leases and Expands Facilities
3M ago
Camp4 Therapeutics prices 5M shares at $6.00 in underwritten public offering
PremiumThe FlyCamp4 Therapeutics prices 5M shares at $6.00 in underwritten public offering
3M ago
Camp4 Therapeutics 5M share Secondary priced at $6.00
Premium
The Fly
Camp4 Therapeutics 5M share Secondary priced at $6.00
3M ago
Camp4 Therapeutics, GSK enter strategic collaboration
Premium
The Fly
Camp4 Therapeutics, GSK enter strategic collaboration
3M ago
Camp4 Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyCamp4 Therapeutics initiated with an Overweight at Cantor Fitzgerald
6M ago
Camp4 Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Camp4 Therapeutics initiated with an Overweight at Cantor Fitzgerald
6M ago
CAMP4 Initiates GLP Toxicology Studies for CMP-SYNGAP-01
Premium
Company Announcements
CAMP4 Initiates GLP Toxicology Studies for CMP-SYNGAP-01
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100